Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1994 1
1995 3
1996 6
1997 1
1998 1
1999 2
2000 2
2001 2
2002 2
2003 2
2004 4
2005 1
2006 1
2008 2
2009 2
2010 2
2011 2
2012 4
2013 4
2014 1
2015 3
2016 4
2017 1
2018 3
2019 3
2020 2
2021 4
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Gallbladder Polyps: Rare Lesions in Childhood.
Demirbaş F, Çaltepe G, Comba A, Bilgin MC, Eren E, Abbasguliyev H, Kalayci AG. Demirbaş F, et al. Among authors: kalayci ag. J Pediatr Gastroenterol Nutr. 2019 Jun;68(6):e89-e93. doi: 10.1097/MPG.0000000000002269. J Pediatr Gastroenterol Nutr. 2019. PMID: 30889123
Inflammatory bowel disease in Turkish children.
Cakir M, Unal F, Dinler G, Baran M, Yuksekkaya HA, Tumgor G, Kasirga E, Kalayci AG, Aydogdu S. Cakir M, et al. Among authors: kalayci ag. World J Pediatr. 2015 Nov;11(4):331-7. doi: 10.1007/s12519-015-0042-2. Epub 2015 Oct 11. World J Pediatr. 2015. PMID: 26454438
Lane-Hamilton syndrome: association or coincidence.
Paksu S, Paksu MS, Kalayci AG, Sancak R. Paksu S, et al. Among authors: kalayci ag. Indian Pediatr. 2012 Mar;49(3):243-4. Indian Pediatr. 2012. PMID: 22484746 Free article.
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study.
Ozen A, Chongsrisawat V, Sefer AP, Kolukisa B, Jalbert JJ, Meagher KA, Brackin T, Feldman HB, Baris S, Karakoc-Aydiner E, Ergelen R, Fuss IJ, Moorman H, Suratannon N, Suphapeetiporn K, Perlee L, Harari OA, Yancopoulos GD, Lenardo MJ; Pozelimab CHAPLE Working Group. Ozen A, et al. Lancet. 2024 Feb 17;403(10427):645-656. doi: 10.1016/S0140-6736(23)02358-9. Epub 2024 Jan 23. Lancet. 2024. PMID: 38278170 Clinical Trial.
64 results